Heather Miller

Dr. Heather Miller

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2019 in ACS Infectious Diseases
Verified
Journal Article
Closed access
NCNicholas Cutrona
Nicholas Cutrona
KGKyra Renee Gillard
Kyra Renee Gillard
RURebecca Joy Ulrich
Rebecca Joy Ulrich
MSMikaela Seemann
Mikaela Seemann
HMHeather Miller
Heather Miller
MBMeghan Blackledge
Meghan Blackledge

15 July 2021 in Biochemistry and Molecular Biology Education
Verified
Journal Article
Closed access
PDF file
HMHeather Miller
Heather Miller
MSMelissa C. Srougi
Melissa C. Srougi

9 February 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RBRachel Berndsen
Rachel Berndsen
TCTaylor Cunningham
Taylor Cunningham
LKLauren Kaelin
Lauren Kaelin
MCMakayla Callender
Makayla Callender
WBW. Dexter Boldog
W. Dexter Boldog
MBMeghan Blackledge
Meghan Blackledge


28 December 2023 in ACS Infectious Diseases
Verified
Journal Article
Open access
BVBrianna L. Viering
Brianna L. Viering
HBHalie Balogh
Halie Balogh
CCChloe F. Cox
Chloe F. Cox
OKOwee K. Kirpekar
Owee K. Kirpekar
AAA. Luke Akers
A. Luke Akers
HMHeather Miller
Heather Miller
Methicillin-resistant Staphylococcus aureus (MRSA) has evolved to become resistant to multiple classes of antibiotics. New antibiotics are costly to develop and deploy, and they have a limited effective lifespan. Antibiotic adjuvants are molecules that potentiate existing antibiotics through nontoxic mechanisms. We previously reported that loratadine, the active ingredient in Claritin, potentiates multiple cell-wall active antibiotics in vitro and disrupts biofilm formation through a hypothesized inhibition of the master regulatory kinase Stk1. Loratadine and oxacillin combined repressed the expression of key antibiotic resistance genes in the bla and mec operons. We hypothesized that additional genes involved in antibiotic resistance, biofilm formation, and other cellular pathways would be modulated when looking transcriptome-wide. To test this, we used RNA-seq to quantify transcript levels and found significant effects in gene expression, including genes controlling virulence, antibiotic resistance, metabolism, transcription (core RNA polymerase subunits and sigma factors), and translation (a plethora of genes encoding ribosomal proteins and elongation factor Tu). We further demonstrated the impacts of these transcriptional effects by investigating loratadine treatment on intracellular ATP levels, persister formation, and biofilm formation and morphology. Loratadine minimized biofilm formation in vitro and enhanced the survival of infected Caenorhabditis elegans. These pleiotropic effects and their demonstrated outcomes on MRSA virulence and survival phenotypes position loratadine as an attractive anti-infective against MRSA.

31 January 2011 in RNA
Verified
Journal Article
Open access
PDF file
HMHeather Miller
Heather Miller
TRTimothy J. Robinson
Timothy J. Robinson
RGRaluca Gordân
Raluca Gordân
AHAlexander J. Hartemink
Alexander J. Hartemink
MGMariano A. Garcia-Blanco
Mariano A. Garcia-Blanco
Tat specific factor 1 (Tat-SF1) interacts with components of both the transcription and splicing machineries and has been classified as a transcription-splicing factor. Although its function as an HIV-1 dependency factor has been investigated, relatively little is known about the cellular functions of Tat-SF1. To identify target genes of Tat-SF1, we utilized a combination of RNAi and exon-specific microarrays. These arrays, which survey genome-wide changes in transcript and individual exon levels, revealed 450 genes with transcript level changes upon Tat-SF1 depletion. Strikingly, 98% of these target genes were down-regulated upon depletion, indicating that Tat-SF1 generally activates gene expression. We also identified 89 genes that showed differential exon level changes after Tat-SF1 depletion. The 89 genes showed evidence of many different types of alternative exon use consistent with the regulation of transcription initiation sites and RNA processing. Minimal overlap between genes with transcript-level and exon-level changes suggests that Tat-SF1 does not functionally couple transcription and splicing. Biological processes significantly enriched with transcript- and exon-level targets include the cell cycle and nucleic acid metabolism; the insulin signaling pathway was enriched with Tat-SF1 transcript-level targets but not exon-level targets. Additionally, a hexamer, ATGCCG, was over-represented in the promoter region of genes showing changes in transcription initiation upon Tat-SF1 depletion. This may represent a novel motif that Tat-SF1 recognizes during transcription. Together, these findings suggest that Tat-SF1 functions independently in transcription and splicing of cellular genes.